InspireMD Inc (NSPR)-Product Pipeline Analysis, 2017 Update

InspireMD Inc (NSPR)-Product Pipeline Analysis, 2017 Update


  • Products Id :- GDME8187PD
  • |
  • Pages: 34
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

InspireMD Inc (InspireMD), formerly Saguaro Resources Inc is a medical device company that develops and commercializes stent platform MGuard technology. The company's products include carotid embolic prevention system, Mguard embolic prevention system and Mguard prime. Its MGuard is based on net that is wrapped with an expandable MicroNet. InspireMD uses MGuard technology, which develops products that are applied in interventional cardiology and other vascular procedures. The company's MGuard prime include mesh sleeve wrapped around a cobalt-chromium stent. It utilizes its technology to make products and offers solutions for various disease conditions such as stenting, embolic showers, restenosis and late stent thrombosis. The company markets its products through a network of distributors in Israel and Germany. InspireMD is headquartered in Tel Aviv, Israel.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company InspireMD Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

InspireMD Inc Company Overview 5

InspireMD Inc Company Snapshot 5

InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview 5

InspireMD Inc-Pipeline Analysis Overview 8

InspireMD Inc-Key Facts 8

InspireMD Inc-Major Products and Services 9

InspireMD Inc Pipeline Products by Development Stage 10

InspireMD Inc Ongoing Clinical Trials by Trial Status 12

InspireMD Inc Pipeline Products Overview 14

CGuard Embolic Prevention System 14

CGuard Embolic Prevention System Product Overview 14

MGuard Drug Eluting Stent 15

MGuard Drug Eluting Stent Product Overview 15

MGuard Embolic Protection Stent 16

MGuard Embolic Protection Stent Product Overview 16

MGuard Embolic Protection Stent Clinical Trial 17

MGuard Prime EPS 18

MGuard Prime EPS Product Overview 18

MGuard Prime EPS Clinical Trial 19

Next Gen CGuard-5F 20

Next Gen CGuard-5F Product Overview 20

NGuard Neurovascular 21

NGuard Neurovascular Product Overview 21

PVGuard Peripheral 22

PVGuard Peripheral Product Overview 22

RGuard Renal 23

RGuard Renal Product Overview 23

InspireMD Inc-Key Competitors 24

InspireMD Inc-Key Employees 25

InspireMD Inc-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 27

InspireMD Inc, Recent Developments 27

Jun 08, 2017: InspireMD Announces Distribution Agreement for CGuard EPS in Taiwan 27

Jun 07, 2017: InspireMD Announces the Publication of an Investigator Initiated Clinical Registry Reaffirming MGuard Prime as a Highly Effective Tool to Prevent Heart Damage in Coronary Artery Blockages with High Thrombotic Content 27

Jun 05, 2017: InspireMD Announces Distribution Agreement for CGuard EPS in Poland 27

Jun 02, 2017: InspireMD Announces Appointment of Paul Stuka as Chairman of the Board 28

May 30, 2017: InspireMD Announces First Two Patients in Hong Kong Successfully Treated with CGuard EPS 28

May 01, 2017: InspireMD Announces Distribution Agreement for CGuardM EPS in Germany 29

Apr 06, 2017: InspireMD Announces Distribution Agreement for CGuard EPS in the Netherlands 29

Apr 04, 2017: InspireMD Announces Distribution Agreement for CGuard in Turkey 29

Mar 30, 2017: InspireMD Announces Commercial Launch of CGuard EPS in the Russian Federation at the ICCA Stroke Event In Moscow 30

Mar 21, 2017: InspireMD Announces Distribution Agreement for CGuard EPS in Hong Kong 30

Appendix 31

Methodology 31

About GlobalData 33

Contact Us 33

Disclaimer 33

List of Figures

InspireMD Inc Pipeline Products by Equipment Type 6

InspireMD Inc Pipeline Products by Development Stage 10

InspireMD Inc Ongoing Clinical Trials by Trial Status 12

List of Tables

InspireMD Inc Pipeline Products and Ongoing Clinical Trials Overview 5

InspireMD Inc Pipeline Products by Equipment Type 6

InspireMD Inc Pipeline Products by Indication 7

InspireMD Inc Ongoing Clinical Trials by Trial Status 7

InspireMD Inc, Key Facts 8

InspireMD Inc, Major Products and Services 9

InspireMD Inc Number of Pipeline Products by Development Stage 10

InspireMD Inc Pipeline Products Summary by Development Stage 11

InspireMD Inc Ongoing Clinical Trials by Trial Status 12

InspireMD Inc Ongoing Clinical Trials Summary 13

CGuard Embolic Prevention System-Product Status 14

CGuard Embolic Prevention System-Product Description 14

MGuard Drug Eluting Stent-Product Status 15

MGuard Drug Eluting Stent-Product Description 15

MGuard Embolic Protection Stent-Product Status 16

MGuard Embolic Protection Stent-Product Description 16

MGuard Embolic Protection Stent-Impact of Polyethylene Terephthalate Micronet Mesh-covered Stent (MGuard) on Coronary Microcirculation's Lesions in Patients with Non ST-segment Elevation Myocardial Infarction (NSTE-ACS): Assessment by Index of Microcirculatory Resistance (IMR) 17

MGuard Embolic Protection Stent-Long Term Outcomes of MGuard Stent Deployment in Saphenous Vein Grafts and Native Coronary Arteries 17

MGuard Prime EPS-Product Status 18

MGuard Prime EPS-Product Description 18

MGuard Prime EPS-Long Term Outcomes of MGuard Stent Deployment in Saphenous Vein Grafts and Native Coronary Arteries 19

Next Gen CGuard-5F-Product Status 20

Next Gen CGuard-5F-Product Description 20

NGuard Neurovascular-Product Status 21

NGuard Neurovascular-Product Description 21

PVGuard Peripheral-Product Status 22

PVGuard Peripheral-Product Description 22

RGuard Renal-Product Status 23

RGuard Renal-Product Description 23

InspireMD Inc, Key Employees 25

InspireMD Inc, Other Locations 26

InspireMD Inc, Subsidiaries 26

Glossary 32

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

InspireMD Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53940
Site License
USD 1500 INR 107880
Corporate User License
USD 2250 INR 161820

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com